
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (16): 2013-2019.DOI: 10.12114/j.issn.1007-9572.2023.0009
Special Issue: 内分泌代谢性疾病最新文章合辑
• Original Research·Focus on Population Health • Previous Articles Next Articles
Received:2023-01-16
Revised:2023-03-15
Published:2023-06-05
Online:2023-03-23
Contact:
ZHOU Shangcheng
通讯作者:
周尚成
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0009
| 年份(年) | 粗发病率 | 标化发病率 | 粗死亡率 | 标化死亡率 |
|---|---|---|---|---|
| 1990 | 162.73 | 176.23 | 5.92 | 9.20 |
| 1991 | 169.77 | 182.00 | 5.88 | 9.02 |
| 1992 | 176.18 | 186.99 | 5.94 | 8.99 |
| 1993 | 181.88 | 191.06 | 6.04 | 9.02 |
| 1994 | 186.99 | 194.02 | 6.11 | 8.98 |
| 1995 | 190.85 | 195.78 | 6.21 | 8.98 |
| 1996 | 193.58 | 196.11 | 6.43 | 9.13 |
| 1997 | 195.10 | 195.36 | 6.63 | 9.23 |
| 1998 | 196.23 | 194.19 | 6.91 | 9.42 |
| 1999 | 197.92 | 193.29 | 7.28 | 9.71 |
| 2000 | 200.84 | 193.33 | 7.63 | 9.95 |
| 2001 | 207.64 | 196.58 | 7.99 | 10.20 |
| 2002 | 218.63 | 203.40 | 8.46 | 10.54 |
| 2003 | 231.56 | 211.57 | 8.86 | 10.74 |
| 2004 | 244.00 | 218.85 | 9.32 | 11.03 |
| 2005 | 253.23 | 222.99 | 9.59 | 11.10 |
| 2006 | 258.50 | 223.54 | 9.28 | 10.45 |
| 2007 | 261.56 | 222.25 | 9.16 | 10.04 |
| 2008 | 263.44 | 220.16 | 9.24 | 9.88 |
| 2009 | 265.25 | 218.38 | 9.43 | 9.85 |
| 2010 | 268.30 | 217.96 | 9.68 | 9.88 |
| 2011 | 272.83 | 219.18 | 9.85 | 9.79 |
| 2012 | 277.65 | 221.18 | 9.96 | 9.62 |
| 2013 | 281.99 | 223.27 | 10.15 | 9.54 |
| 2014 | 285.17 | 224.81 | 10.46 | 9.53 |
| 2015 | 286.32 | 225.11 | 10.69 | 9.45 |
| 2016 | 273.35 | 216.22 | 11.10 | 9.52 |
| 2017 | 259.74 | 206.90 | 11.43 | 9.51 |
| 2018 | 260.08 | 205.03 | 11.76 | 9.46 |
| 2019 | 265.45 | 204.31 | 12.16 | 9.44 |
Table 1 Diabetes incidence and deaths in China,1990—2019
| 年份(年) | 粗发病率 | 标化发病率 | 粗死亡率 | 标化死亡率 |
|---|---|---|---|---|
| 1990 | 162.73 | 176.23 | 5.92 | 9.20 |
| 1991 | 169.77 | 182.00 | 5.88 | 9.02 |
| 1992 | 176.18 | 186.99 | 5.94 | 8.99 |
| 1993 | 181.88 | 191.06 | 6.04 | 9.02 |
| 1994 | 186.99 | 194.02 | 6.11 | 8.98 |
| 1995 | 190.85 | 195.78 | 6.21 | 8.98 |
| 1996 | 193.58 | 196.11 | 6.43 | 9.13 |
| 1997 | 195.10 | 195.36 | 6.63 | 9.23 |
| 1998 | 196.23 | 194.19 | 6.91 | 9.42 |
| 1999 | 197.92 | 193.29 | 7.28 | 9.71 |
| 2000 | 200.84 | 193.33 | 7.63 | 9.95 |
| 2001 | 207.64 | 196.58 | 7.99 | 10.20 |
| 2002 | 218.63 | 203.40 | 8.46 | 10.54 |
| 2003 | 231.56 | 211.57 | 8.86 | 10.74 |
| 2004 | 244.00 | 218.85 | 9.32 | 11.03 |
| 2005 | 253.23 | 222.99 | 9.59 | 11.10 |
| 2006 | 258.50 | 223.54 | 9.28 | 10.45 |
| 2007 | 261.56 | 222.25 | 9.16 | 10.04 |
| 2008 | 263.44 | 220.16 | 9.24 | 9.88 |
| 2009 | 265.25 | 218.38 | 9.43 | 9.85 |
| 2010 | 268.30 | 217.96 | 9.68 | 9.88 |
| 2011 | 272.83 | 219.18 | 9.85 | 9.79 |
| 2012 | 277.65 | 221.18 | 9.96 | 9.62 |
| 2013 | 281.99 | 223.27 | 10.15 | 9.54 |
| 2014 | 285.17 | 224.81 | 10.46 | 9.53 |
| 2015 | 286.32 | 225.11 | 10.69 | 9.45 |
| 2016 | 273.35 | 216.22 | 11.10 | 9.52 |
| 2017 | 259.74 | 206.90 | 11.43 | 9.51 |
| 2018 | 260.08 | 205.03 | 11.76 | 9.46 |
| 2019 | 265.45 | 204.31 | 12.16 | 9.44 |
| 年份(年) | 男 | 女 | 总计 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| YLL率 | YLD率 | DALY率 | YLL率 | YLD率 | DALY率 | YLL率 | YLD率 | DALY率 | |
| 1990 | 182.77 | 265.20 | 447.97 | 228.56 | 255.81 | 484.38 | 204.71 | 260.74 | 465.46 |
| 1991 | 179.78 | 275.92 | 455.70 | 222.13 | 259.88 | 482.01 | 199.92 | 267.96 | 467.88 |
| 1992 | 179.13 | 285.06 | 464.19 | 219.79 | 263.12 | 482.91 | 198.31 | 274.00 | 472.31 |
| 1993 | 178.69 | 292.33 | 471.01 | 219.58 | 265.57 | 485.14 | 197.93 | 278.72 | 476.65 |
| 1994 | 178.56 | 297.46 | 476.02 | 218.20 | 267.06 | 485.25 | 197.04 | 281.92 | 478.97 |
| 1995 | 180.71 | 300.12 | 480.83 | 215.85 | 267.47 | 483.32 | 196.87 | 283.38 | 480.25 |
| 1996 | 183.84 | 299.57 | 483.42 | 216.65 | 266.20 | 482.85 | 198.82 | 282.38 | 481.21 |
| 1997 | 186.54 | 296.47 | 483.01 | 216.63 | 263.32 | 479.95 | 200.05 | 279.27 | 479.33 |
| 1998 | 190.72 | 292.54 | 483.27 | 219.62 | 259.99 | 479.61 | 203.58 | 275.51 | 479.09 |
| 1999 | 195.69 | 289.45 | 485.14 | 224.42 | 257.34 | 481.75 | 208.45 | 272.53 | 480.98 |
| 2000 | 200.16 | 288.95 | 489.11 | 226.81 | 256.50 | 483.31 | 211.98 | 271.82 | 483.80 |
| 2001 | 203.66 | 296.40 | 500.06 | 229.60 | 263.27 | 492.87 | 215.13 | 278.98 | 494.12 |
| 2002 | 209.42 | 312.42 | 521.84 | 235.17 | 278.78 | 513.95 | 220.75 | 294.90 | 515.66 |
| 2003 | 211.55 | 331.50 | 543.05 | 238.95 | 297.48 | 536.43 | 223.71 | 313.98 | 537.69 |
| 2004 | 217.71 | 348.39 | 566.10 | 241.54 | 313.53 | 555.08 | 227.93 | 330.62 | 558.55 |
| 2005 | 219.76 | 357.70 | 577.46 | 238.63 | 321.32 | 559.95 | 227.37 | 339.25 | 566.62 |
| 2006 | 207.44 | 359.47 | 566.91 | 222.84 | 321.45 | 544.29 | 213.40 | 340.24 | 553.64 |
| 2007 | 200.61 | 358.33 | 558.94 | 210.38 | 319.23 | 529.61 | 203.71 | 338.59 | 542.29 |
| 2008 | 199.44 | 355.74 | 555.18 | 201.69 | 315.82 | 517.50 | 198.68 | 335.61 | 534.30 |
| 2009 | 199.38 | 353.02 | 552.40 | 195.52 | 312.11 | 507.62 | 195.41 | 332.42 | 527.83 |
| 2010 | 200.69 | 351.70 | 552.39 | 190.74 | 309.27 | 500.02 | 193.56 | 330.37 | 523.93 |
| 2011 | 199.10 | 352.76 | 551.86 | 185.51 | 307.14 | 492.65 | 190.01 | 329.82 | 519.84 |
| 2012 | 199.24 | 355.46 | 554.69 | 177.55 | 304.90 | 482.46 | 185.71 | 330.02 | 515.73 |
| 2013 | 198.18 | 358.49 | 556.66 | 172.74 | 302.53 | 475.26 | 182.63 | 330.30 | 512.94 |
| 2014 | 198.23 | 360.64 | 558.88 | 169.93 | 299.85 | 469.77 | 181.34 | 330.00 | 511.34 |
| 2015 | 198.05 | 360.72 | 558.77 | 166.28 | 296.82 | 463.10 | 179.36 | 328.51 | 507.87 |
| 2016 | 199.38 | 350.30 | 549.68 | 166.12 | 288.55 | 454.67 | 179.95 | 319.23 | 499.18 |
| 2017 | 198.41 | 337.89 | 536.30 | 165.60 | 279.67 | 445.27 | 179.49 | 308.65 | 488.14 |
| 2018 | 197.54 | 337.67 | 535.21 | 164.86 | 280.27 | 445.12 | 178.92 | 308.81 | 487.73 |
| 2019 | 197.55 | 344.86 | 542.41 | 163.86 | 288.17 | 452.02 | 178.45 | 316.30 | 494.76 |
Table 2 Burden of diabetes in China,1990—2019
| 年份(年) | 男 | 女 | 总计 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| YLL率 | YLD率 | DALY率 | YLL率 | YLD率 | DALY率 | YLL率 | YLD率 | DALY率 | |
| 1990 | 182.77 | 265.20 | 447.97 | 228.56 | 255.81 | 484.38 | 204.71 | 260.74 | 465.46 |
| 1991 | 179.78 | 275.92 | 455.70 | 222.13 | 259.88 | 482.01 | 199.92 | 267.96 | 467.88 |
| 1992 | 179.13 | 285.06 | 464.19 | 219.79 | 263.12 | 482.91 | 198.31 | 274.00 | 472.31 |
| 1993 | 178.69 | 292.33 | 471.01 | 219.58 | 265.57 | 485.14 | 197.93 | 278.72 | 476.65 |
| 1994 | 178.56 | 297.46 | 476.02 | 218.20 | 267.06 | 485.25 | 197.04 | 281.92 | 478.97 |
| 1995 | 180.71 | 300.12 | 480.83 | 215.85 | 267.47 | 483.32 | 196.87 | 283.38 | 480.25 |
| 1996 | 183.84 | 299.57 | 483.42 | 216.65 | 266.20 | 482.85 | 198.82 | 282.38 | 481.21 |
| 1997 | 186.54 | 296.47 | 483.01 | 216.63 | 263.32 | 479.95 | 200.05 | 279.27 | 479.33 |
| 1998 | 190.72 | 292.54 | 483.27 | 219.62 | 259.99 | 479.61 | 203.58 | 275.51 | 479.09 |
| 1999 | 195.69 | 289.45 | 485.14 | 224.42 | 257.34 | 481.75 | 208.45 | 272.53 | 480.98 |
| 2000 | 200.16 | 288.95 | 489.11 | 226.81 | 256.50 | 483.31 | 211.98 | 271.82 | 483.80 |
| 2001 | 203.66 | 296.40 | 500.06 | 229.60 | 263.27 | 492.87 | 215.13 | 278.98 | 494.12 |
| 2002 | 209.42 | 312.42 | 521.84 | 235.17 | 278.78 | 513.95 | 220.75 | 294.90 | 515.66 |
| 2003 | 211.55 | 331.50 | 543.05 | 238.95 | 297.48 | 536.43 | 223.71 | 313.98 | 537.69 |
| 2004 | 217.71 | 348.39 | 566.10 | 241.54 | 313.53 | 555.08 | 227.93 | 330.62 | 558.55 |
| 2005 | 219.76 | 357.70 | 577.46 | 238.63 | 321.32 | 559.95 | 227.37 | 339.25 | 566.62 |
| 2006 | 207.44 | 359.47 | 566.91 | 222.84 | 321.45 | 544.29 | 213.40 | 340.24 | 553.64 |
| 2007 | 200.61 | 358.33 | 558.94 | 210.38 | 319.23 | 529.61 | 203.71 | 338.59 | 542.29 |
| 2008 | 199.44 | 355.74 | 555.18 | 201.69 | 315.82 | 517.50 | 198.68 | 335.61 | 534.30 |
| 2009 | 199.38 | 353.02 | 552.40 | 195.52 | 312.11 | 507.62 | 195.41 | 332.42 | 527.83 |
| 2010 | 200.69 | 351.70 | 552.39 | 190.74 | 309.27 | 500.02 | 193.56 | 330.37 | 523.93 |
| 2011 | 199.10 | 352.76 | 551.86 | 185.51 | 307.14 | 492.65 | 190.01 | 329.82 | 519.84 |
| 2012 | 199.24 | 355.46 | 554.69 | 177.55 | 304.90 | 482.46 | 185.71 | 330.02 | 515.73 |
| 2013 | 198.18 | 358.49 | 556.66 | 172.74 | 302.53 | 475.26 | 182.63 | 330.30 | 512.94 |
| 2014 | 198.23 | 360.64 | 558.88 | 169.93 | 299.85 | 469.77 | 181.34 | 330.00 | 511.34 |
| 2015 | 198.05 | 360.72 | 558.77 | 166.28 | 296.82 | 463.10 | 179.36 | 328.51 | 507.87 |
| 2016 | 199.38 | 350.30 | 549.68 | 166.12 | 288.55 | 454.67 | 179.95 | 319.23 | 499.18 |
| 2017 | 198.41 | 337.89 | 536.30 | 165.60 | 279.67 | 445.27 | 179.49 | 308.65 | 488.14 |
| 2018 | 197.54 | 337.67 | 535.21 | 164.86 | 280.27 | 445.12 | 178.92 | 308.81 | 487.73 |
| 2019 | 197.55 | 344.86 | 542.41 | 163.86 | 288.17 | 452.02 | 178.45 | 316.30 | 494.76 |
| 年份(年) | 1型糖尿病 | 2型糖尿病 | ||||
|---|---|---|---|---|---|---|
| 标化发病率 | 标化死亡率 | DALY率 | 标化发病率 | 标化死亡率 | DALY率 | |
| 1990 | 1.96 | 0.57 | 29.65 | 174.27 | 8.63 | 435.81 |
| 1991 | 1.95 | 0.55 | 28.93 | 180.05 | 8.47 | 438.95 |
| 1992 | 1.94 | 0.55 | 28.70 | 185.05 | 8.44 | 443.61 |
| 1993 | 1.94 | 0.54 | 28.41 | 189.12 | 8.48 | 448.24 |
| 1994 | 1.94 | 0.55 | 28.94 | 192.08 | 8.43 | 450.03 |
| 1995 | 1.94 | 0.55 | 29.39 | 193.84 | 8.43 | 450.86 |
| 1996 | 1.95 | 0.55 | 29.27 | 194.16 | 8.57 | 451.94 |
| 1997 | 1.98 | 0.55 | 29.02 | 193.38 | 8.68 | 450.31 |
| 1998 | 2.01 | 0.56 | 29.48 | 192.18 | 8.86 | 449.61 |
| 1999 | 2.05 | 0.56 | 29.57 | 191.24 | 9.15 | 451.41 |
| 2000 | 2.09 | 0.56 | 29.15 | 191.24 | 9.40 | 454.66 |
| 2001 | 2.13 | 0.54 | 28.31 | 194.45 | 9.66 | 465.81 |
| 2002 | 2.19 | 0.52 | 27.05 | 201.21 | 10.02 | 488.61 |
| 2003 | 2.27 | 0.49 | 25.77 | 209.30 | 10.25 | 511.92 |
| 2004 | 2.34 | 0.47 | 25.13 | 216.51 | 10.55 | 533.42 |
| 2005 | 2.42 | 0.45 | 24.09 | 220.58 | 10.65 | 542.53 |
| 2006 | 2.49 | 0.42 | 22.96 | 221.05 | 10.04 | 530.68 |
| 2007 | 2.58 | 0.39 | 22.06 | 219.67 | 9.65 | 520.24 |
| 2008 | 2.67 | 0.37 | 21.54 | 217.49 | 9.51 | 512.75 |
| 2009 | 2.74 | 0.36 | 21.05 | 215.64 | 9.49 | 506.78 |
| 2010 | 2.78 | 0.34 | 20.46 | 215.17 | 9.54 | 503.47 |
| 2011 | 2.80 | 0.33 | 19.65 | 216.38 | 9.47 | 500.18 |
| 2012 | 2.80 | 0.31 | 18.78 | 218.38 | 9.31 | 496.96 |
| 2013 | 2.80 | 0.29 | 18.23 | 220.47 | 9.24 | 494.70 |
| 2014 | 2.79 | 0.29 | 17.89 | 222.01 | 9.24 | 493.45 |
| 2015 | 2.81 | 0.28 | 17.49 | 222.30 | 9.17 | 490.38 |
| 2016 | 2.84 | 0.27 | 17.39 | 213.38 | 9.25 | 481.78 |
| 2017 | 2.90 | 0.27 | 17.36 | 204.01 | 9.24 | 470.78 |
| 2018 | 3.03 | 0.27 | 17.68 | 202.00 | 9.19 | 470.05 |
| 2019 | 3.26 | 0.27 | 18.24 | 201.06 | 9.17 | 476.52 |
Table 3 Burden of type 1 and type 2 diabetes in China,1990—2019
| 年份(年) | 1型糖尿病 | 2型糖尿病 | ||||
|---|---|---|---|---|---|---|
| 标化发病率 | 标化死亡率 | DALY率 | 标化发病率 | 标化死亡率 | DALY率 | |
| 1990 | 1.96 | 0.57 | 29.65 | 174.27 | 8.63 | 435.81 |
| 1991 | 1.95 | 0.55 | 28.93 | 180.05 | 8.47 | 438.95 |
| 1992 | 1.94 | 0.55 | 28.70 | 185.05 | 8.44 | 443.61 |
| 1993 | 1.94 | 0.54 | 28.41 | 189.12 | 8.48 | 448.24 |
| 1994 | 1.94 | 0.55 | 28.94 | 192.08 | 8.43 | 450.03 |
| 1995 | 1.94 | 0.55 | 29.39 | 193.84 | 8.43 | 450.86 |
| 1996 | 1.95 | 0.55 | 29.27 | 194.16 | 8.57 | 451.94 |
| 1997 | 1.98 | 0.55 | 29.02 | 193.38 | 8.68 | 450.31 |
| 1998 | 2.01 | 0.56 | 29.48 | 192.18 | 8.86 | 449.61 |
| 1999 | 2.05 | 0.56 | 29.57 | 191.24 | 9.15 | 451.41 |
| 2000 | 2.09 | 0.56 | 29.15 | 191.24 | 9.40 | 454.66 |
| 2001 | 2.13 | 0.54 | 28.31 | 194.45 | 9.66 | 465.81 |
| 2002 | 2.19 | 0.52 | 27.05 | 201.21 | 10.02 | 488.61 |
| 2003 | 2.27 | 0.49 | 25.77 | 209.30 | 10.25 | 511.92 |
| 2004 | 2.34 | 0.47 | 25.13 | 216.51 | 10.55 | 533.42 |
| 2005 | 2.42 | 0.45 | 24.09 | 220.58 | 10.65 | 542.53 |
| 2006 | 2.49 | 0.42 | 22.96 | 221.05 | 10.04 | 530.68 |
| 2007 | 2.58 | 0.39 | 22.06 | 219.67 | 9.65 | 520.24 |
| 2008 | 2.67 | 0.37 | 21.54 | 217.49 | 9.51 | 512.75 |
| 2009 | 2.74 | 0.36 | 21.05 | 215.64 | 9.49 | 506.78 |
| 2010 | 2.78 | 0.34 | 20.46 | 215.17 | 9.54 | 503.47 |
| 2011 | 2.80 | 0.33 | 19.65 | 216.38 | 9.47 | 500.18 |
| 2012 | 2.80 | 0.31 | 18.78 | 218.38 | 9.31 | 496.96 |
| 2013 | 2.80 | 0.29 | 18.23 | 220.47 | 9.24 | 494.70 |
| 2014 | 2.79 | 0.29 | 17.89 | 222.01 | 9.24 | 493.45 |
| 2015 | 2.81 | 0.28 | 17.49 | 222.30 | 9.17 | 490.38 |
| 2016 | 2.84 | 0.27 | 17.39 | 213.38 | 9.25 | 481.78 |
| 2017 | 2.90 | 0.27 | 17.36 | 204.01 | 9.24 | 470.78 |
| 2018 | 3.03 | 0.27 | 17.68 | 202.00 | 9.19 | 470.05 |
| 2019 | 3.26 | 0.27 | 18.24 | 201.06 | 9.17 | 476.52 |
| [1] | |
| [2] |
《中国心血管健康与疾病报告》编写组. 《中国心血管健康与疾病报告2020》概述[J]. 中国心血管病研究,2021,19(7):582-590. DOI:10.3969/j.issn.1672-5301.2021.07.002.
|
| [3] |
丁贤彬,毛德强,焦艳,等. 重庆市糖尿病患病率、死亡率及伤残调整寿命年率分析[J]. 上海交通大学学报(医学版),2021,41(1):78-81. DOI:10.3969/j.issn.1674-8115.2021.01.014.
|
| [4] |
陈文婕,钱永刚,初迪,等. 1990—2019年内蒙古自治区糖尿病疾病负担趋势研究[J]. 疾病监测,2022,37(6):826-831. DOI:10.3784/jbjc.202110150546.
|
| [5] |
官昊宇,俞浩,罗鹏飞,等. 1990—2019年江苏省居民2型糖尿病疾病负担及其变化趋势分析[J]. 中国慢性病预防与控制,2022,30(9):666-671. DOI:10.16386/j.cjpccd.issn.1004-6194.2022.09.006.
|
| [6] |
徐英,李志学,马艳,等. 1990—2019年中国成年人归因于2型糖尿病的癌症疾病负担研究[J]. 中国肿瘤,2022,31(12):959-966.
|
| [7] |
GBD Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories,1990—2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1223-1249. DOI:10.1016/S0140-6736(20)30752-2.
|
| [8] |
|
| [9] |
杨明,汪舒文,宇传华. 1990—2019年中国皮肤恶性肿瘤疾病负担状况及发病趋势预测[J]. 中国肿瘤,2022,31(11):853-861. DOI:10.11735/j.issn.1004-0242.2022.11.A002.
|
| [10] |
GBD. Global fertility,mortality,migration,and population forecasts 2017—2100[EB/OL]. [2022-11-15].
|
| [11] |
郑荣寿,陈万青. 基于贝叶斯方法的年龄-时期-队列预测模型的介绍[J]. 中华预防医学杂志,2012,46(7):648-650. DOI:10.3760/cma.j.issn.0253-9624.2012.07.016.
|
| [12] |
许晴晴,严永富,陈浩,等. 中国四大慢性病死亡率可持续发展目标实现的预测研究[J]. 中华流行病学杂志,2022,43(6):878-884. DOI:10.3760/cma.j.cn112338-20211028-00830.
|
| [13] |
International Diabetes Federation. IDF diabetes atlas[EB/OL]. [2022-11-15].
|
| [14] |
|
| [15] |
黎倩欣,周尚成,陈飘飘,等. 深圳市糖尿病疾病经济负担研究[J]. 卫生经济研究,2021,38(3):63-66. DOI:10.14055/j.cnki.33-1056/f.2021.03.032.
|
| [16] |
王俊,王丽丹,江启成,等. 我国糖尿病直接医疗费用研究系统评价[J]. 现代预防医学,2018,45(3):462-466,490.
|
| [17] | |
| [18] |
彭莉,韩攀. Ⅱ型糖尿病患者的体力活动水平、静坐时间与其糖脂代谢的关系[J]. 现代预防医学,2017,44(23):4391-4394.
|
| [19] |
姜莹莹,刘敏,吉宁,等. 1990—2016年中国高BMI导致的糖尿病疾病负担研究[J]. 中华流行病学杂志,2019,40(1):46-51. DOI:10.3760/cma.j.issn.0254-6450.2019.01.010.
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
袁晓霞,钟艾霖,周尚成,等. 2017—2019年广州市糖尿病早死概率及疾病负担分析[J]. 现代预防医学,2021,48(5):784-788.
|
| [24] |
| [1] | TANG Haoqing, LI Mingyue, LONG Ren, ZHU Yinbo, LIANG Weihuan, ZHU Ping, ZHAO Wei, ZHAO Yang, LIU Xiaoyun. Management Burden of Diabetic Mellitus Patients with Multimorbidity among Middle Aged and Older Adults: a Cross-sectional Survey in 6 Community Medical Institutes of China [J]. Chinese General Practice, 2026, 29(32): 4786-4797. |
| [2] | TIAN Xiangyang, ZHOU Yingsheng, GAO Ying. Prospects of Behavioral and Lifestyle Interventions for Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(31): 4513-4520. |
| [3] | XIAO Zhili, LU Chenxia, ZHU Hui, ZHANG Jia, CHEN Zhuangzhuang, SUN Wei, LIU Xiangchuxuan, LUO Cheng, XIAO Mingzhong, LI Xiaodong. Application and Future Prospects of CGM Technology in Co-management of MAFLD and T2DM [J]. Chinese General Practice, 2026, 29(31): 4521-4527. |
| [4] | YAN Ziwei, NIE Jiahua, SHI Yan, WEI Limin. Correlation between the Albumin/Gamma-glutamyl Transferase Ratio and Metabolic-associated Fatty Liver Disease in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(30): 4431-4437. |
| [5] | ZHAO Peizhen, ZHAO Zhendong, XU Haizhu. Exploratory Study on Screening of Multiple Inherited Metabolic Disorders in Newborns in Hainan Province [J]. Chinese General Practice, 2026, 29(30): 4438-4444. |
| [6] | WANG Lin, CAO Chenchen, HUANG Yichong, LIU Jing. Development of Preference Attributes and Levels of Family Doctor Contract Services for Patients with Comorbidity of Hypertension and Type 2 Diabetes Mellitus Based on Discrete Choice Experiments [J]. Chinese General Practice, 2026, 29(29): 4232-4240. |
| [7] | ZHAO Congjuan, JIN Tiantian, LIANG Jie, WANG Beining, GAO Yan. Comparative Effectiveness of GLP-1 Receptor Agonists on Patients with Diabetic Kidney Disease: a Network Meta-analysis [J]. Chinese General Practice, 2026, 29(29): 4326-4336. |
| [8] | YU Xinyan, ZHANG Fang, GU Zhile, WANG Yanfang, SU Peng, ZHANG Haicheng. Correlation between Fasting Plasma Glucose, Body Mass Index, and Waist Circumference among Community-dwelling Elderly Individuals [J]. Chinese General Practice, 2026, 29(28): 4132-4140. |
| [9] | JIANG Chen, AN Ni, XU Yunjing, NIU Shaona, LI Fengming, JIANG Liangmei. A Cross-sectional Study of Hospitalization Characteristics and Healthcare Resource Consumption of Patients with Cardiovascular-kidney-metabolic Syndrome [J]. Chinese General Practice, 2026, 29(28): 4172-4178. |
| [10] | WU Yuqiong, CHU Xiangling, HUANG Youye, SUN Li, JIANG Tian, ZHANG Qiu, HU Honglin. A Case Report and Literature Review of Hepatocyte Nuclear Factor 4α Gene Mutation Leading to Maturity-onset Diabetes of the Young [J]. Chinese General Practice, 2026, 29(27): 4011-4015. |
| [11] | QU Furong, JIN Jiaqi, XUE Guijun, LYU Qingguo, LI Zhipeng, LI Jing, LI Sheyu. Interpretation of the BMJ Living Clinical Practice Guideline on Pharmacological Management of Type 2 Diabetes Based on Cardiovascular-renal Event Prevention and Weight Management [J]. Chinese General Practice, 2026, 29(27): 3873-3878. |
| [12] | WANG Jiaxuan, WANG Zhaoxian, HUANG Xiaofen, ZHAO Jinkui, LABA Sangzhu. Spatiotemporal Patterns and Determinants of Dengue in China during 2004-2023 [J]. Chinese General Practice, 2026, 29(26): 3844-3850. |
| [13] | WANG Yanyan, DONG Xiaoxue, KONG Jinchen, CHEN Yutong, ZHAI Yujie, JIANG Shuai. Analysis of Mortality Trends of Cervical, Endometrial, and Ovarian Cancers among Women in China from 2004 to 2021 [J]. Chinese General Practice, 2026, 29(26): 3838-3843. |
| [14] | PAN Hao, QIU Yong, LIU Rongmei, GUO Zhiping, DAI Nengguang, JIN Tong, SANG Yanhong, LI Yi, LIAO Lijuan. Impact of Basic Public Health Service Management on Hospitalization Economic Burden and Survival Outcomes in Patients: a Study of Hospitalized Patients with Diabetes [J]. Chinese General Practice, 2026, 29(25): 3599-3607. |
| [15] | XUE Cuirong, WEI Wei, WU Renyuan, XUE Yaqin, XU Huijiang, LYU Weijiang, JIANG Dandan. Prevalence and Management Status of Chronic Kidney Disease in Hypertensive and Type 2 Diabetic Populations: a Community-based Cross-sectional Study [J]. Chinese General Practice, 2026, 29(25): 3650-3654. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||